ZMAPP Supply Runs Out. Dallas Patient not to be Treated with Drug. Obola Briefed. Reports of a 2nd Case being Investigated! CDC to hold press conference at 5:30PM EDT
Investmentwatchblog.com
October 1st, 2014
First Ebola patient diagnosed in US won’t be treated with ZMapp
Stocks of experimental drug used to treat several international health workers – at least two of them Americans – have run out
The Ebola patient in Dallas will not be given ZMapp, the experimental drug used to treat several international aid workers and medical staff, including at least two Americans, because stocks have run out.
ZMapp is one of the drugs that is being rushed into trials in the epidemic, along with other drugs that will need more safety data in animals and humans before they are administered to patients.
There have been very few doses available and stocks have now all been used up, but the San Diego-based company behind ZMapp is now pressing ahead with the manufacture of more supplies. It is not an easy drug to make, however. It includes three man-made antibodies to the virus which are grown in tobacco leaves and takes months to produce.
The Rest…HERE
